26/09/2005 Solvay and Pronova Biocare sign license agreement for Omacor® SOLVAY PHARMACEUTICALS and PRONOVA BIOCARE (Norway) announce today the signing of an additional license and supply agreement for OMACOR®, a product indicated for the secondary prevention after myocardial infarction (MI) and hypertriglyceridemia.
02/08/2005 Solvay and Berna Biotech sign a license agreement for Aerugen® Solvay Pharmaceuticals and Berna Biotech Ltd announce today that they have signed a commercialization and license agreement for Aerugen®, a vaccine for the prevention of Pseudomonas aeruginosa (PA) infection in Cystic Fibrosis (CF) patients.
12/07/2005 Solvay finalizes agreement to buy Fournier Pharma Solvay announced today that it has signed a final purchase agreement with the shareholders of Fournier Pharma for the acquisition of 100% of the company.
